Atlas Trials

Detection of Plasma DNA Methylation in Peripheral Blood From Patients With Resectable Liver Cancer

Clinical trial NCT04856046 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04856046
Sponsor
Mayo Clinic
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Resectable Hepatocellular Carcinoma
Start date
2021-11-06
Primary completion
2029-12-04
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.